Using high-resolution micro-CT with bones exposed to fire could help forensic investigators determine the timing of murders.
Radiomics could soon be used to solve mysteries or crimes, according to newly presented research.
It is possible, according to investigators from the Radiology Institute at the University of Padova, for radiomics to reliably evaluate changes in bone structure due to fire exposure. In fact, specific features of radiomics can determine intervals of combustion.
The team presented their findings during the Radiological Society of North America (RSNA) annual meeting this year.
Being able to better assess these intervals is critical, said lead study author Amalia Lupi, M.D., because fire is frequently used to hide bodies after murders.
“In forensic scenarios with corpse concealment by combustion, every detail can be crucial to investigation,” she said.
By using radiomics, investigators can establish a timeline for the fire exposure, offering key details for a forensic investigation. In this study, Lupi’s team looked at the role radiomics can play in characterizing these time intervals. Based on their analysis, they proposed a method that can be used to gather more information that can further a crime investigation.
The team used high-resolution CT to examine 15 samples of human fibulae both before and after fire exposure for three combustion intervals, and they removed any samples that fractured after the second exposure. For the remaining bones, they collected information on bone density and volume, as well as 55 radiomics features.
According to that data, Lupi said, radiomics is able to detect changes in bone dependent on time and exposure.
For additional RSNA coverage, click here.
Can Radiomics Bolster Low-Dose CT Prognostic Assessment for High-Risk Lung Adenocarcinoma?
December 16th 2024A CT-based radiomic model offered over 10 percent higher specificity and positive predictive value for high-risk lung adenocarcinoma in comparison to a radiographic model, according to external validation testing in a recent study.
The Reading Room: Artificial Intelligence: What RSNA 2020 Offered, and What 2021 Could Bring
December 5th 2020Nina Kottler, M.D., chief medical officer of AI at Radiology Partners, discusses, during RSNA 2020, what new developments the annual meeting provided about these technologies, sessions to access, and what to expect in the coming year.
Study Shows Merits of CTA-Derived Quantitative Flow Ratio in Predicting MACE
December 11th 2024For patients with suspected or known coronary artery disease (CAD) without percutaneous coronary intervention (PCI), researchers found that those with a normal CTA-derived quantitative flow ratio (CT-QFR) had a 22 percent higher MACE-free survival rate.
Can MRI-Based AI Bolster Biopsy Decision-Making in PI-RADS 3 Cases?
December 9th 2024In patients with PI-RADS 3 lesion assessments, the combination of AI and prostate-specific antigen density (PSAD) level achieved a 78 percent sensitivity and 93 percent negative predictive value for clinically significant prostate cancer (csPCa), according to research presented at the Radiological Society of North American (RSNA) conference.